Status
Conditions
Treatments
About
The study aims to validate both the predictive capacity and the clinical usability of the Clinical Decision Support System (CDSS) developed within the PREPARE project (European Union Grant Agreement 101080288 PREPARE HORIZON-HLTH-2022-TOOL-12-01) for the management of idiopathic scoliosis (IS). This will be achieved through simulation-based studies.
Full description
Study Population:
Three participant groups will be included:
All participants must have adequate cognitive and language abilities to take part in discussions and complete questionnaires.
Sample Size:
Part I: Involves the 8 ISICO physicians performing clinical visits.
The main outcome measure is the variation in treatment decisions before and after exposure to the CDSS.
With α = 0.05, power = 80%, and expected effect size (Cohen's d = 0.3), the minimum required sample size is 175 clinical cases.
Parts II-III (Focus Groups):
6-12 patients
6-12 parents
6-10 physicians These group sizes align with qualitative research standards to ensure thematic saturation.
Safety Evaluation:
Adverse events will be monitored, recorded, and assessed by the Data Safety Monitoring Committee (DSMC).
Statistical and Analytical Plan:
Quantitative analysis will evaluate:
The frequency, nature, and motivations behind changes in treatment plans after using CDSS recommendations.
Correlations between CDSS suggestions and clinicians' treatment decisions.
Qualitative analysis will interpret data from focus group discussions to identify patterns, trends, and associations between CDSS recommendations, clinical choices, and possible alternative decisions had the CDSS been applied.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Initial visits or follow-up appointments of patients with IS attending the Milan site of ISICO - Italian Scientific Spine Institute for rehabilitative treatment;
Age between 10 and 18 years;
Informed consent to participate in the study
Exclusion criteria
Visits not related to the treatment of IS (other spinal conditions);
Patients undergoing treatment at other clinics or hospitals.
Primary purpose
Allocation
Interventional model
Masking
178 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal